NCT01977820 - Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Phenylketonuria

Interventions

DRUG

Sapropterin

Sapropterin tablets will be administered orally once daily at a dose of 20 milligram per kilogram (mg/kg) during both the 2-Week response test period and 24-Week study period.

DRUG

Placebo

Sapropterin tablets will be administered orally once daily at a dose of 20 milligram per kilogram (mg/kg) during both the 2-Week response test period and Placebo tablets matching to sapropterin will be administered orally once daily during the 24-Week study period.

Trial Locations (2)

Unknown

Research Site, Bologna

Research site, Lausanne